Aspirin use for primary and secondary prophylaxis of cardiovascular disease

Current Therapeutic Research - Clinical and Experimental

Volumn 62, Issue 10, 2001, Pages 676-690

  Hassan, Mariam ^a,b   Amonkar, Mayur ^a  

^a WEST VIRGINIA UNIVERSITY   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

Author keywords

Aspirin; Cardiovascular disease; Prevalence; Primary prevention; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; AGED; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DRUG USE; FEMALE; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR;

EID: 0035196581     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(01)80075-8     Document Type: Article

References (28)

1. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients
2. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
3. Final Report on the aspirin component of the ongoing Physicians' Health Study
4. Thrombosis Prevention Trial: Randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk
5. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
6. Aspirin as a therapeutic agent in cardiovascular disease: A statement for professionals from the American Heart Association
7. Internal analgesic, antipyretic, and antirheumatic drug products for over-the-counter human use; final rule for professional labeling of aspirin, buffered aspirin, and aspirin in combination with antacid drug products
8. Aspirin therapy in diabetes (position statement)
9. Aspirin use is low among United States outpatients with coronary artery disease
10. Mis-medication and under-utilization of aspirin in the prevention and treatment of cardiovascular disease
11. Prevalence and population characteristics of aspirin use in the primary and secondary prevention of cardiovascular disease
12. Aspirin for secondary prevention after acute myocardial infarction in the elderly: Prescribed use and outcomes
13. Patterns of aspirin use in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study
14. Guidelines for the early management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on assessment of diagnostic and therapeutic cardiovascular procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction)
15. Guidelines for medical treatment for stroke prevention
16. Sampling methods for random digit dialing
17. Using behavioral risk factor surveillance data
18. The Women's Health Study: Summary of the study design
19. Aspirin use among adults with diabetes: Estimates from the Third National Health and Nutrition Examination Survey
20. Underuse of cardiac procedures: Do women, ethnic minorities, and the uninsured fail to receive needed revascularization?
21. Use of cardiovascular procedures among black persons and white persons: A 7-year nationwide study in patients with renal disease
22. The Behavioral Risk Factor Surveillance System Questionnaire: Its reliability in a statewide sample
23. The Behavioral Risk Factor Survey and the Stanford Five-City Project Survey: A comparison of cardiovascular risk behavior estimates